170 related articles for article (PubMed ID: 31555275)
1. TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells.
Tawfik D; Groth C; Gundlach JP; Peipp M; Kabelitz D; Becker T; Oberg HH; Trauzold A; Wesch D
Front Immunol; 2019; 10():2044. PubMed ID: 31555275
[TBL] [Abstract][Full Text] [Related]
2. Influence of Indoleamine-2,3-Dioxygenase and Its Metabolite Kynurenine on γδ T Cell Cytotoxicity against Ductal Pancreatic Adenocarcinoma Cells.
Jonescheit H; Oberg HH; Gonnermann D; Hermes M; Sulaj V; Peters C; Kabelitz D; Wesch D
Cells; 2020 May; 9(5):. PubMed ID: 32384638
[TBL] [Abstract][Full Text] [Related]
3. Myeloid molecular characteristics of human γδ T cells support their acquisition of tumor antigen-presenting capacity.
Muto M; Baghdadi M; Maekawa R; Wada H; Seino K
Cancer Immunol Immunother; 2015 Aug; 64(8):941-9. PubMed ID: 25904200
[TBL] [Abstract][Full Text] [Related]
4. Payload-delivering engineered γδ T cells display enhanced cytotoxicity, persistence, and efficacy in preclinical models of osteosarcoma.
Fowler D; Barisa M; Southern A; Nattress C; Hawkins E; Vassalou E; Kanouta A; Counsell J; Rota E; Vlckova P; Draper B; De Mooij T; Farkas A; Brezovjakova H; Baker AT; Scotlandi K; Manara MC; Tape C; Chester K; Anderson J; Fisher J
Sci Transl Med; 2024 May; 16(749):eadg9814. PubMed ID: 38809963
[TBL] [Abstract][Full Text] [Related]
5. Histamine modulates γδ-T lymphocyte migration and cytotoxicity, via Gi and Gs protein-coupled signalling pathways.
Truta-Feles K; Lagadari M; Lehmann K; Berod L; Cubillos S; Piehler S; Herouy Y; Barz D; Kamradt T; Maghazachi A; Norgauer J
Br J Pharmacol; 2010 Nov; 161(6):1291-300. PubMed ID: 20977468
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic modulation of immune synaptic-cytoskeletal networks potentiates γδ T cell-mediated cytotoxicity in lung cancer.
Weng RR; Lu HH; Lin CT; Fan CC; Lin RS; Huang TC; Lin SY; Huang YJ; Juan YH; Wu YC; Hung ZC; Liu C; Lin XH; Hsieh WC; Chiu TY; Liao JC; Chiu YL; Chen SY; Yu CJ; Tsai HC
Nat Commun; 2021 Apr; 12(1):2163. PubMed ID: 33846331
[TBL] [Abstract][Full Text] [Related]
7. CRISPR screens decode cancer cell pathways that trigger γδ T cell detection.
Mamedov MR; Vedova S; Freimer JW; Sahu AD; Ramesh A; Arce MM; Meringa AD; Ota M; Chen PA; Hanspers K; Nguyen VQ; Takeshima KA; Rios AC; Pritchard JK; Kuball J; Sebestyen Z; Adams EJ; Marson A
Nature; 2023 Sep; 621(7977):188-195. PubMed ID: 37648854
[TBL] [Abstract][Full Text] [Related]
8. Modulation of lytic molecules restrain serial killing in γδ T lymphocytes.
Sandoz PA; Kuhnigk K; Szabo EK; Thunberg S; Erikson E; Sandström N; Verron Q; Brech A; Watzl C; Wagner AK; Alici E; Malmberg KJ; Uhlin M; Önfelt B
Nat Commun; 2023 Sep; 14(1):6035. PubMed ID: 37758698
[TBL] [Abstract][Full Text] [Related]
9. The cytotoxicity of
Liu Y; Zhang T; Deng J; Huang Q; Yang C; Cheng Z
Oncogene; 2023 Dec; 42(49):3648-3654. PubMed ID: 37805664
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming of human γδ T cells by expression of an anti-CD19 TCR fusion construct (εTRuC) to enhance tumor killing.
Juraske C; Krissmer SM; Teuber ES; Parigiani MA; Strietz J; Wesch D; Kabelitz D; Minguet S; Schamel WW
J Leukoc Biol; 2024 Jan; 115(2):293-305. PubMed ID: 38149982
[TBL] [Abstract][Full Text] [Related]
11. Role of γδ T Cells in Cancer Progression and Therapy.
Padmaraju V; Sankla Y; Malla RR
Crit Rev Oncog; 2023; 28(4):59-70. PubMed ID: 38050982
[TBL] [Abstract][Full Text] [Related]
12. Non-signaling Chimeric Antigen Receptors Enhance Antigen-Directed Killing by γδ T Cells in Contrast to αβ T Cells.
Fleischer LC; Becker SA; Ryan RE; Fedanov A; Doering CB; Spencer HT
Mol Ther Oncolytics; 2020 Sep; 18():149-160. PubMed ID: 32671190
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Changes in Tumor Microenvironment: How Could They Affect γδ T Cells Functions?
Corsale AM; Di Simone M; Lo Presti E; Picone C; Dieli F; Meraviglia S
Cells; 2021 Oct; 10(11):. PubMed ID: 34831116
[TBL] [Abstract][Full Text] [Related]
14. Camelid-derived Tcell engagers harnessing human γδ T cells as promising antitumor immunotherapeutic agents.
Boutin L; Barjon C; Chauvet M; Lafrance L; Senechal E; Bourges D; Vigne E; Scotet E
Eur J Immunol; 2024 May; ():e2350773. PubMed ID: 38804118
[TBL] [Abstract][Full Text] [Related]
15. Granzyme B-activated IL18 potentiates αβ and γδ CAR T cell immunotherapy in a tumor-dependent manner.
Hull CM; Larcombe-Young D; Mazza R; George M; Davies DM; Schurich A; Maher J
Mol Ther; 2024 May; ():. PubMed ID: 38745414
[TBL] [Abstract][Full Text] [Related]
16. Unraveling the secrets of γδ T cells with single-cell biology.
Sagar
J Leukoc Biol; 2024 Jan; 115(1):47-56. PubMed ID: 38073484
[TBL] [Abstract][Full Text] [Related]
17. The γδ T cells dual function and crosstalk with intestinal flora in treating colorectal cancer is a promising area of study.
Lin P; Yan Y; Zhang Z; Dong Q; Yi J; Li Q; Zhang A; Kong X
Int Immunopharmacol; 2023 Oct; 123():110733. PubMed ID: 37579540
[TBL] [Abstract][Full Text] [Related]
18. Biologically Active α-Amino Amide Analogs and γδ T Cells-A Unique Anticancer Approach for Leukemia.
Otaibi AA; Sherwani S; Al-Zahrani SA; Alshammari EM; Khan WA; Alsukaibi AKD; Khan SN; Khan MWA
Front Oncol; 2021; 11():706586. PubMed ID: 34322393
[TBL] [Abstract][Full Text] [Related]
19. Cancer immunomodulation using bispecific aptamers.
Thomas BJ; Porciani D; Burke DH
Mol Ther Nucleic Acids; 2022 Mar; 27():894-915. PubMed ID: 35141049
[TBL] [Abstract][Full Text] [Related]
20. Finding the TRAIL to escape granzyme B-mediated liver injury in PSC.
Guicciardi ME; Jalan-Sakrikar N
Hepatology; 2024 Mar; ():. PubMed ID: 38502805
[No Abstract] [Full Text] [Related]
[Next] [New Search]
